Skip to content

BioLife Solutions, Inc.: 10-Q filed 2011-11-14

What BioLife Solutions, Inc. reported in its quarterly report filed 2011-11-14 (fiscal Q3 2011): 33 published measures, 84 facts as tagged in accession 0001354488-11-004366.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-14
Fiscal period
fiscal Q3 2011
Accession
0001354488-11-004366 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioLife Solutions, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-301,564,376USD
At 2010-12-311,309,059USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-3012,385,875USD
At 2010-12-3110,857,971USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-30-10,821,499USD
At 2010-12-31-9,548,912USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-3020,117USD
At 2010-12-313,211USD
At 2010-09-30298USD
At 2009-12-31139,151USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-478,668USD92
2011-01-01 to 2011-09-30-1,545,469USD273
2010-07-01 to 2010-09-30-436,732USD92
2010-01-01 to 2010-09-30-1,512,992USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-797,122USD273
2010-01-01 to 2010-09-30-972,168USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-55,972USD273
2010-01-01 to 2010-09-30-16,685USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-30870,000USD273
2010-01-01 to 2010-09-30850,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-55,972USD273
2010-01-01 to 2010-09-30-16,685USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-53,740,321USD
At 2010-12-31-52,194,852USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-30344,003USD
At 2010-12-31360,700USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-09-30183,657USD273
2010-01-01 to 2010-09-30121,860USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-284,808USD92
2011-01-01 to 2011-09-30-999,097USD273
2010-07-01 to 2010-09-30-286,196USD92
2010-01-01 to 2010-09-30-1,078,878USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-301,044,823USD
At 2010-12-31814,973USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-171,677USD92
2011-01-01 to 2011-09-30-497,458USD273
2010-07-01 to 2010-09-30-150,563USD92
2010-01-01 to 2010-09-30-432,628USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-30516,148USD
At 2010-12-31340,702USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-30310,442USD
At 2010-12-31117,068USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-30458,677USD
At 2010-12-31338,899USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-07-01 to 2011-09-30654,770USD92
2011-01-01 to 2011-09-301,945,191USD273
2010-07-01 to 2010-09-30511,041USD92
2010-01-01 to 2010-09-301,727,996USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-30475,126USD
At 2010-12-31410,486USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-30369,962USD92
2011-01-01 to 2011-09-30946,094USD273
2010-07-01 to 2010-09-30224,845USD92
2010-01-01 to 2010-09-30649,118USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2011-09-3098,903USD92
2011-01-01 to 2011-09-30391,086USD273
2010-07-01 to 2010-09-3098,350USD92
2010-01-01 to 2010-09-30246,784USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3069,679,854shares
At 2010-12-3169,679,854shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-09-30767,107USD
At 2010-12-31713,031USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-09-30-423,104USD
At 2010-12-31-352,331USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-30100,445USD
At 2010-12-31108,015USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-3090,903USD
At 2010-12-3162,377USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30500,424USD92
2011-01-01 to 2011-09-301,356,222USD273
2010-07-01 to 2010-09-30321,337USD92
2010-01-01 to 2010-09-301,149,813USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-09-3070,773USD273
2010-01-01 to 2010-09-3049,635USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-193,860USD92
2011-01-01 to 2011-09-30-546,372USD273
2010-07-01 to 2010-09-30-150,536USD92
2010-01-01 to 2010-09-30-434,114USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-119,778USD273
2010-01-01 to 2010-09-30-1,693USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-64,640USD273
2010-01-01 to 2010-09-30-141,231USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30193,374USD273
2010-01-01 to 2010-09-3036,064USD273

Inspect the source

Entity
BioLife Solutions, Inc. / CIK 0000834365
Captured
2026-09-19T15:08:45.571Z
SEC response SHA-256
cc2cf8f92622e29fea17afa7805fcf370f2d2caa2d36b6cf780e7beb9e287e2f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000834365.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))